SLC2A1 and neoplasm: Arguably the most critical finding of this study is that GLUT1OE GD2-CAR T cells increased tumor control in a NALM6 leukemia model, and this is strongly supported by a similar study that overexpressed GLUT1 in 19-28z and IL13Rα2-BBz CAR T cells [6].